EUVIMEDEUVIMED entdecken
Crossref

Cell‐free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascites

Yu Yamaji, Goh Murayama, Moeko Inoue, Takuya Urita, Takashi Hirayama, Akira Uchiyama, Masaki Nojima, Yukitomo Hagiwara, Takumi Saito, Taiga Kuga, Tomoko Miyashita, Makio Kusaoi und 5 weitere

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1111/1744-9987.70022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Yu Yamaji und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, Ascites, Antigen-Antibody Complex, Plasmapheresis. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cell‐free and concentrated ascites reinfusion therapy (CART) is used for ascites in decompensated cirrhosis and malignant tumors. We investigated extracellular vesicles (EVs) and circulating immune complexes (CICs) as potential inflammatory inducers in ascites and verified whether they can be removed through CART treatment.

Methods

Ascites from 10 patients, including those with cancer, undergoing CART were analyzed. We compared the inflammatory inducers in untreated ascites, ascites processed using AHF‐MO (conventional CART filter), and those filtered with EC20W (double‐filtration plasmapheresis filter). A cell‐based reporter assay measured biological activity.

Results

AHF‐MO significantly lowered EV and CIC levels along with physiological activity in the treated ascites. EC20W was superior in terms of EV removal but showed no significant difference from AHF‐MO in CIC removal. AHF‐MO showed a greater reduction in physiological activity.

Conclusion

The CART process with AHF‐MO effectively removes EVs and CICs, reducing physiological activity and demonstrating its safety in ascites treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesAscitesAntigen-Antibody ComplexPlasmapheresisHumansMaleFemaleMiddle AgedAgedCell-Free SystemNeoplasmsFiltration

Stichwörter der Autor:innen

ascitescell‐free concentrated ascites reinfusion therapycirculating immune complexesextracellular vesicles

Substanzen

Antigen-Antibody Complex

Autor:innen und Institutionen

  • Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
  • Clinical Engineering Department, Juntendo University Hospital, Tokyo, Japan.
  • Department of Obstetrics and Gynecology, Faculty of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
  • Department of Gastroenterology, Juntendo University School of Medicine, Tokyo, Japan.

Zitieren

APA

Yamaji, Y., Murayama, G., Inoue, M., Urita, T., Hirayama, T., Uchiyama, A., Nojima, M., Hagiwara, Y., Saito, T., Kuga, T., Miyashita, T., Kusaoi, M., Terao, Y., Itakura, A., Ikejima, K., Tamura, N., & Yamaji, K. (2025). Cell‐free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascites. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.70022

Vancouver

Yamaji Y, Murayama G, Inoue M, Urita T, Hirayama T, Uchiyama A, et al. Cell‐free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascites. Therapeutic Apheresis and Dialysis. 2025. doi:10.1111/1744-9987.70022

BibTeX
@article{Yamaji2025,
  author = {Yamaji, Yu and Murayama, Goh and Inoue, Moeko and Urita, Takuya and Hirayama, Takashi and Uchiyama, Akira and Nojima, Masaki and Hagiwara, Yukitomo and Saito, Takumi and Kuga, Taiga and Miyashita, Tomoko and Kusaoi, Makio and Terao, Yasuhisa and Itakura, Atsuo and Ikejima, Kenichi and Tamura, Naoto and Yamaji, Ken},
  title = {Cell‐free concentrated ascites reinfusion therapy enables removal of extracellular vesicles and circulating immune complexes in ascites},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1111/1744-9987.70022}
}
Kostenlos starten →